Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction.

Martin BalikAdam NovotnyDaniel SukVojtech MatousekMichal MalyTomas BrozekGuido Tavazzi

Published in: Cardiovascular drugs and therapy (2020)

Vasopressin allowed a reduction of norepinephrine with subsequent LVOTO reduction and hemodynamic improvement of the most severe form of LVOTO, which represented 1.9% of all septic shock patients.

Keyphrases

septic shock
left ventricular
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
prognostic factors
acute myocardial infarction
peritoneal dialysis
hypertrophic cardiomyopathy
mitral valve
aortic stenosis
patient reported outcomes
left atrial
acute coronary syndrome